Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis

Conclusion:
Our data suggest that Sorafenib controls the growth of endometriotic lesions in vitro and in vivo.

Source: Reproductive Sciences - August 10, 2015 Category: Reproduction Medicine Authors: Leconte, M., Santulli, P., Chouzenoux, S., Marcellin, L., Cerles, O., Chapron, C., Dousset, B., Batteux, F. Tags: Original Articles Source Type: research